HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Woo Hyun Park Selected Research

Propyl Gallate

1/2022Propyl gallate decreases the proliferation of Calu-6 and A549 lung cancer cells via affecting reactive oxygen species and glutathione levels.
8/2021Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
12/2020Propyl gallate reduces the growth of lung cancer cells through caspase‑dependent apoptosis and G1 phase arrest of the cell cycle.
8/2013The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
3/2011The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Woo Hyun Park Research Topics

Disease

46Lung Neoplasms (Lung Cancer)
01/2022 - 08/2008
23Neoplasms (Cancer)
01/2021 - 02/2003
14Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2017 - 07/2009
9Necrosis
12/2020 - 05/2010
7Adenocarcinoma
12/2011 - 04/2008
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2004 - 02/2003
4Lymphoma (Lymphomas)
07/2003 - 11/2002
2Mesothelioma
05/2016 - 01/2016
2Hypertension (High Blood Pressure)
06/2011 - 09/2008
2Cardiomegaly (Heart Hypertrophy)
12/2010 - 09/2008
2Renal Cell Carcinoma (Grawitz Tumor)
05/2003 - 04/2003
1Hematologic Neoplasms (Hematological Malignancy)
04/2020
1Vascular Diseases (Vascular Disease)
04/2018
1Inflammation (Inflammations)
01/2016
1Reperfusion Injury
08/2012
1Ischemia
08/2012
1Infarction (Infarctions)
08/2012
1Fibrosis (Cirrhosis)
07/2012
1Esophageal Neoplasms (Esophageal Cancer)
12/2011
1Cardiovascular Diseases (Cardiovascular Disease)
06/2011
1Heart Failure
06/2011
1Hypoxia (Hypoxemia)
12/2010
1Right Ventricular Hypertrophy
12/2010

Drug/Important Bio-Agent (IBA)

38Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2008
37Glutathione (Reduced Glutathione)IBA
01/2022 - 11/2008
11Matrix Metalloproteinases (MMPs)IBA
08/2021 - 05/2010
9benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2012 - 07/2009
8Proteasome InhibitorsIBA
04/2012 - 01/2010
7AntioxidantsIBA
01/2021 - 04/2010
7Histone Deacetylase InhibitorsIBA
04/2020 - 05/2003
7PyrogallolIBA
07/2017 - 08/2008
7Gallic AcidIBA
07/2013 - 05/2010
6Caspase InhibitorsIBA
09/2018 - 11/2008
5Propyl GallateIBA
01/2022 - 03/2011
5Mitogen-Activated Protein KinasesIBA
08/2021 - 05/2010
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2021 - 01/2010
5Arsenic Trioxide (Trisenox)FDA Link
04/2020 - 08/2008
5Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2018 - 08/2012
5CaspasesIBA
04/2018 - 11/2008
5Cysteine (L-Cysteine)FDA Link
01/2016 - 04/2010
5Biological ProductsIBA
05/2013 - 01/2011
4AcidsIBA
05/2016 - 11/2010
4Buthionine SulfoximineIBA
01/2016 - 08/2008
4Atrial Natriuretic Factor (ANF)IBA
12/2010 - 09/2008
4Antimycin AIBA
01/2010 - 09/2008
4Monensin (Coban)IBA
07/2003 - 11/2002
3Phosphotransferases (Kinase)IBA
08/2021 - 06/2010
3Auranofin (Ridaura)FDA Link
12/2020 - 02/2015
3VorinostatFDA Link
12/2017 - 05/2016
3Proteins (Proteins, Gene)FDA Link
12/2017 - 09/2008
3Histone Deacetylases (Histone Deacetylase)IBA
12/2017 - 05/2016
3ThioredoxinsIBA
05/2016 - 03/2015
3pyrimidin-2-one beta-ribofuranosideIBA
11/2014 - 10/2012
3IonophoresIBA
07/2003 - 02/2003
2EnzymesIBA
01/2021 - 05/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020 - 08/2012
2Thioredoxin-Disulfide ReductaseIBA
12/2020 - 01/2016
2Valproic Acid (Depakote)FDA LinkGeneric
04/2020 - 12/2013
2Caspase 3 (Caspase-3)IBA
04/2018 - 05/2016
2MethyltransferasesIBA
11/2014 - 04/2013
2A-Form DNA (A-DNA)IBA
11/2014 - 04/2013
2urotensin IIIBA
08/2012 - 12/2010
1tempolIBA
01/2021
1Annexin A5IBA
01/2021
1Culture MediaIBA
12/2020
1ArsenicIBA
04/2018
1Superoxides (Superoxide)IBA
02/2018
1Fluorescein-5-isothiocyanate (FITC)IBA
02/2018
1Messenger RNA (mRNA)IBA
12/2017
1Caspase 8 (Caspase-8)IBA
03/2017
1Type I Tumor Necrosis Factor ReceptorsIBA
03/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2017
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
03/2017
1Caspase 9IBA
03/2017
1AsbestosIBA
01/2016
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
08/2013
1trichostatin A (A 300)IBA
01/2013
1theasinensin AIBA
01/2013
1Krebs-Henseleit solutionIBA
08/2012
1parthenolideIBA
07/2012
1SesquiterpenesIBA
07/2012
1LactonesIBA
07/2012
1Thioacetamide (Thioacetamid)IBA
07/2012
1Aligeron (AS 2)IBA
04/2012
1leucinalIBA
12/2011
1leucylleucine (Leu-Leu)IBA
12/2011
1Paclitaxel (Taxol)FDA LinkGeneric
12/2011
1Butylated Hydroxyanisole (BHA)IBA
03/2011
1MonocrotalineIBA
12/2010
1Type C PhospholipasesIBA
12/2010
1Pen(5)-Trp(7)-Orn(8)- urotensin II (4-11)IBA
12/2010
1Inositol (Myoinositol)IBA
12/2010
1Protein Kinase CIBA
12/2010
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2010
1MitogensIBA
06/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2010
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
05/2010
1Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
04/2010
1Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA
11/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2011